Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine

ClinicalTrials.gov ID: NCT05216263

Public ClinicalTrials.gov record NCT05216263. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Multicenter 24-Week Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Atogepant When Added to OnabotulinumtoxinA (BOTOX) for the Preventive Treatment of Chronic Migraine

Study identification

NCT ID
NCT05216263
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
75 participants

Conditions and interventions

Interventions

  • Atogepant Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 21, 2022
Primary completion
May 1, 2025
Completion
May 1, 2025
Last update posted
Jun 15, 2026

2022 – 2025

United States locations

U.S. sites
29
U.S. states
18
U.S. cities
28
Facility City State ZIP Site status
Neurology and Neurodiagnostics of Alabama /ID# 242538 Hoover Alabama 35244-5700
Barrow Neurological Institute - Dignity Health St. Joseph's Hosp and Medical Ctr /ID# 241812 Phoenix Arizona 85013
Arkansas Clinical Research /ID# 241789 Little Rock Arkansas 72205
Hope Clinical Research /ID# 241772 Canoga Park California 91303
Profound Research LLC /ID# 244084 Carlsbad California 92011-4213
Neuro Pain Medical Center /ID# 241992 Fresno California 93710
Neurological Research Institute /ID# 242688 Santa Monica California 90404
Neurology Offices of South Florida, PLLC /ID# 242693 Boca Raton Florida 33428-2231
Coastal Clinical Research Specialists /ID# 247992 Jacksonville Beach Florida 32250-1694
University of Miami /ID# 252230 Miami Florida 33136
First Physicians Group - Waldemere /ID# 242861 Sarasota Florida 34239-2943
Kansas Institute of Research /ID# 241796 Overland Park Kansas 66211-1363
Duplicate_Ochsner Clinic Foundation /ID# 241803 Covington Louisiana 70433-8107
Beth Israel Deaconess Medical Center /ID# 241800 Boston Massachusetts 02215-5400
Michigan Headache & Neurological Institute (MHNI) /ID# 241784 Ann Arbor Michigan 48104-5131
Minneapolis Clinic of Neurology - Burnsville /ID# 241994 Burnsville Minnesota 55337-6732
Albany Medical College /ID# 242757 Albany New York 12208
Dent Neurologic Institute - Amherst /ID# 241776 Amherst New York 14226
Headache Wellness Center /ID# 241791 Greensboro North Carolina 27405
Jefferson Hospital for Neuroscience /ID# 243712 Philadelphia Pennsylvania 19107-5191
Preferred Primary Care Physicians - Jacob Murphy /ID# 241798 Uniontown Pennsylvania 15401
Chattanooga Medical Research /ID# 253295 Chattanooga Tennessee 37404-3239
Nashville Neuroscience Group /ID# 243592 Nashville Tennessee 37203
Texas Neurology /ID# 241795 Dallas Texas 75214
Inova Health System /ID# 252242 Falls Church Virginia 22042
Integrated Neurology Services - Falls Church /ID# 244747 Falls Church Virginia 22043-2367
Puget Sound Neurology /ID# 241787 Tacoma Washington 25328
Frontier Clinical Research - Kingwood /ID# 242928 Kingwood West Virginia 26537-9797
West Virginia Univ School Med /ID# 252869 Morgantown West Virginia 26506

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05216263, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 15, 2026 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05216263 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →